2-methylpropyl tetradecyl ether

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 2-methylpropyl tetradecyl ether
• 英文别名: Isobutyl tetradecyl ether；1-(2-methylpropoxy)tetradecane
• 化学式: C₁₈H₃₈O
• 分子量: 270.499
• InChiKey: WMSPFJNZFZJMJS-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  8.1
• 重原子数：
  19
• 可旋转键数：
  15
• 环数：
  0.0
• sp3杂化的碳原子比例：
  1.0
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  十四醇 、 异丁醛 在 palladium on activated charcoal 氢气 作用下， 反应 10.0h， 以96%的产率得到2-methylpropyl tetradecyl ether
  参考文献：
  名称：

  一种从醇和羰基化合物合成醚的简便催化方法

  摘要：

  二烷基醚和烷基氟烷基醚是由醇和羰基化合物在Pd/C存在下，在氢气、W...

  DOI：

  10.1246/bcsj.78.456

文献信息

• A Convenient Catalytic Method for the Synthesis of Ethers from Alcohols and Carbonyl Compounds
  作者：Yasuyuki Fujii、Hisakazu Furugaki、Shinji Yano、Katsumi Kita

  DOI：10.1246/cl.2000.926

  日期：2000.8

  Unsymmetrical ethers are obtained in excellent yields by the catalytic etherification of alcohols with ketones or aldehydes in the presence of Pd/C under an atmospheric pressure of hydrogen when water produced by the reaction is continuously removed by bubbling hydrogen through the reaction mixture.

  当反应产生的水通过反应混合物中的氢气鼓泡连续除去时，在 Pd/C 存在下，在氢气压力下，通过醇与酮或醛的催化醚化反应，以极好的收率获得不对称醚。
• Biodegradable lipids for delivery of nucleic acids
  申请人：TRANSLATE BIO, INC.

  公开号：US10022455B2

  公开（公告）日：2018-07-17

  The present invention provides, in part, a biodegradable compound of formula I, and sub-formulas thereof: Formula (I) or a pharmaceutically acceptable salt thereof, where each X independently is O or S, each Y independently is O or S, and each R1 independently is defined herein; and a liposome composition comprising the cationic lipid of formula I or a sub-formula thereof, and methods of delivering agents, such as nucleic acids including mRNA, in vivo, by administering to a subject the liposome comprising the cationic lipid of formula I or a sub-formula thereof, where the agent is encapsulated within the liposome.

  本发明提供了一种生物可降解的化合物，其化学式为I，以及其子式：化学式（I）或其药学上可接受的盐，其中每个X独立地为O或S，每个Y独立地为O或S，每个R1独立地在此处定义；以及包含化学式I或其子式的阳离子脂质的脂质体组合物，以及通过向主体给予包含化学式I或其子式的阳离子脂质的脂质体来递送药剂（例如核酸，包括mRNA）的方法，在此过程中，药剂被封装在脂质体内。
• AMINOALCOHOL LIPIDOIDS AND USES THEREOF
  申请人：Mahon Kerry Peter

  公开号：US20110293703A1

  公开（公告）日：2011-12-01

  Aminoalcohol lipidoids are prepared by reacting an amine with an epoxide-terminated compound are described. Methods of preparing aminoalcohol lipidoids from commercially available starting materials are also provided. Aminoalcohol lipidoids may be prepared from racemic or stereochemically pure epoxides. Aminoalcohol lipidoids or salts forms thereof are preferably biodegradable and biocompatible and may be used in a variety of drug delivery systems. Given the amino moiety of these aminoalcohol lipidoid compounds, they are particularly suited for the delivery of polynucleotides. Complexes, micelles, liposomes or particles containing the inventive lipidoids and polynucleotide have been prepared. The inventive lipidoids may also be used in preparing microparticles for drug delivery. They are particularly useful in delivering labile agents given their ability to buffer the pH of their surroundings.

  本文描述了通过将胺与环氧末端化合物反应制备氨基醇脂质体的方法。还提供了从商业起始材料制备氨基醇脂质体的方法。氨基醇脂质体可以从外消旋或立体化学纯的环氧化合物制备。氨基醇脂质体或其盐形式最好是可生物降解和生物相容的，并可用于各种药物输送系统。鉴于这些氨基醇脂质体化合物的氨基基团，它们特别适用于多核苷酸的输送。已经制备了包含创新脂质体和多核苷酸的复合物、胶束、脂质体或粒子。创新脂质体也可以用于制备药物输送的微粒。鉴于它们能够缓冲其周围环境的pH值，它们在输送不稳定剂方面特别有用。
• CONJUGATED LIPOMERS AND USES THEREOF
  申请人：Dahlman James E.

  公开号：US20120251560A1

  公开（公告）日：2012-10-04

  The present invention provides inventive conjugated polyethyleneimine (PEI) polymers and conjugated aza-macrocycles (collectively referred to herein as “conjugated lipomers” or “lipomers”) containing one or more groups of the formula (iii): wherein R 3 and R 4 are as defined herein. Also provided are compositions comprising the inventive conjugated lipomers, and methods of preparation and use.
• AMINO ACID-, PEPTIDE-AND POLYPEPTIDE-LIPIDS, ISOMERS, COMPOSITIONS, AND USES THEREOF
  申请人：Massachusetts Institute of Technology

  公开号：US20130158021A1

  公开（公告）日：2013-06-20

  Described herein are compounds and compositions characterized, in certain embodiments, by conjugation of various groups, such as lipophilic groups, to an amino or amide group of an amino acid, a linear or cyclic peptide, a linear or cyclic polypeptide, or structural isomer thereof, to provide compounds of the present invention, collectively referred to herein as “APPLs”. Such APPLs are deemed useful for a variety of applications, such as, for example, improved nucleotide delivery. Exemplary APPLs include, but are not limited to, compounds of Formula (I), (II), (III), (IV), (V), and (VI), and salts thereof, as described herein: wherein m, n, p, R′, R 1 , R 2 , R 3 , R 4 , R 5 , R 8 , Z, W, Y, and Z are as defined herein.